Dosage forms and method for ameliorating male erectile dysfunction
US5770606A · kind A · utility
50Cited by
9References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 20, 1995 |
| Grant date | Jun 23, 1998 |
| Priority date | — |
| Expiry date | Oct 20, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.